Viewing StudyNCT00098683

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-05 @ 11:39 AM
Last Modification Date: 2024-10-26 @ 9:11 AM
Study NCT ID: NCT00098683
Status: COMPLETED
Last Update Posted: 2014-02-13
First Post: 2004-12-07
Brief Title: Amifostine in Treating Young Patients With Newly Diagnosed De Novo Myelodysplastic Syndromes
Sponsor: Childrens Oncology Group
Organization: Childrens Oncology Group
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
MyelodysplasticMyeloproliferative Neoplasms
Myelodysplastic Syndromes
Keywords:
Name View
refractory cytopenia with multilineage dysplasia View
refractory anemia with excess blasts View
refractory anemia View
refractory anemia with ringed sideroblasts View
de novo myelodysplastic syndromes View
myelodysplasticmyeloproliferative neoplasm unclassifiable View